| P2093 | author name string | Brett M Mitchell | |
| | Kristina J Young | |
| | Piyali Chatterjee | |
| | Valorie L Chiasson | |
| | Hoanglan Nguyen | |
| | Shelley E Kopriva | |
| P2860 | cites work | Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production | Q24291773 |
| | ERK1/2 signaling dominates over RhoA signaling in regulating early changes in RNA expression induced by endothelin-1 in neonatal rat cardiomyocytes | Q33549651 |
| | Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction | Q33642021 |
| | TLR signals promote IL-6/IL-17-dependent transplant rejection. | Q33711191 |
| | Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. | Q33950554 |
| | Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? | Q34443514 |
| | IL-17 induces autoantibody overproduction and peripheral blood mononuclear cell overexpression of IL-6 in lupus nephritis patients | Q73698956 |
| | Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors | Q77787649 |
| | Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities | Q79182194 |
| | Effect of fasudil on macrovascular disorder-induced endothelial dysfunction | Q79366253 |
| | Removal of FKBP12/12.6 from endothelial ryanodine receptors leads to an intracellular calcium leak and endothelial dysfunction | Q80264403 |
| | Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease | Q80483198 |
| | Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension | Q80552078 |
| | IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation | Q83187595 |
| | Myeloperoxidase (MPO) and interleukin-17 (IL-17) plasma levels are increased in patients with acute coronary syndromes | Q84201343 |
| | New insights into the role of IL-17 in inflammatory bowel disease | Q85043290 |
| | Inflammation, immunity, and hypertension | Q34528283 |
| | Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions. | Q34583004 |
| | Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. | Q34765324 |
| | Inhibition of the AMP-activated protein kinase-α2 accentuates agonist-induced vascular smooth muscle contraction and high blood pressure in mice | Q34950411 |
| | FK506 binding protein 12 deficiency in endothelial and hematopoietic cells decreases regulatory T cells and causes hypertension | Q35024911 |
| | Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. | Q35456291 |
| | Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction | Q36229028 |
| | Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation | Q36535244 |
| | The IL-17 cytokine family. | Q36617097 |
| | An overview of IL-17 function and signaling | Q37243055 |
| | Is hypertension an immunologic disease? | Q37307983 |
| | The role of IL-23/IL-17 axis in lupus nephritis | Q37397437 |
| | T lymphocytes: a role in hypertension? | Q37664405 |
| | IL-17 in systemic lupus erythematosus | Q37727813 |
| | Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease | Q37735334 |
| | TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection | Q37773292 |
| | Association analysis of polymorphisms at the interleukin-1 locus in essential hypertension | Q37872597 |
| | Transforming growth factor-beta1 regulates macrophage migration via RhoA. | Q38510172 |
| | Cellular mechanisms of IL-17-induced blood-brain barrier disruption | Q39770425 |
| | Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of L-arginine metabolism to efficient nitric oxide production | Q40638231 |
| | HIF-1α mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinoma | Q40655023 |
| | Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension | Q41956748 |
| | Tacrolimus reduces nitric oxide synthase function by binding to FKBP rather than by its calcineurin effect | Q42448517 |
| | FK506 binding protein 12/12.6 depletion increases endothelial nitric oxide synthase threonine 495 phosphorylation and blood pressure | Q42507560 |
| | Reduced endothelial NO-cGMP vascular relaxation pathway during TNF-alpha-induced hypertension in pregnant rats | Q42515767 |
| | IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts | Q43997188 |
| | Reduced endothelial NO-cGMP-mediated vascular relaxation and hypertension in IL-6-infused pregnant rats | Q44715072 |
| | Mechanisms of soluble beta-amyloid impairment of endothelial function | Q45023573 |
| | In vivo effects of interleukin-17 on haematopoietic cells and cytokine release in normal mice | Q45153206 |
| | IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. | Q45960055 |
| | Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia | Q46332630 |
| | The effects of interleukin-6 on the contraction and relaxation responses of the cavernous smooth muscle from rats | Q46539077 |
| | IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy | Q46930205 |
| | Rho kinase regulates renal blood flow by modulating eNOS activity in ischemia-reperfusion of the rat kidney | Q46981497 |
| | Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. | Q47909675 |
| | A pathogenic role of IL- 17 at the early stage of corneal allograft rejection | Q48025939 |
| | Serum levels of interleukin (IL)-13, IL-17 and IL-18 in patients with ischemic heart disease | Q48029821 |
| | Renal NF-kappaB activation and TNF-alpha upregulation correlate with salt-sensitive hypertension in Dahl salt-sensitive rats. | Q51937701 |
| | The effect of interleukin-17 on hematopoietic cells and cytokine release in mouse spleen. | Q53944856 |
| | IL-17 Contributes to the Development of Chronic Rejection in a Murine Heart Transplant Model | Q57273010 |
| | Rho kinase contributes to basal vascular tone in humans: role of endothelium-derived nitric oxide | Q60722959 |
| | Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus | Q73086966 |
| P433 | issue | 4 | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 696-704 | |
| P577 | publication date | 2012-12-21 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension | |
| P478 | volume | 97 | |